Countries must intensify efforts to track HIV and hepatitis C virus (HCV) incidence among people who inject drugs, and to prioritize this group in prevention and elimination work, according to new University of Bristol-led research, published online in The Lancet Gastroenterology & Hepatology.
Vaccine gap ‘fueling Nigeria’s diphtheria outbreak’
Low vaccine coverage and weak infrastructure have fueled a recurrence of diphtheria in Nigeria, especially in rural areas beset by poor access to healthcare services, public health experts say.
Periodontists and family doctors must collaborate to treat their patients’ overall health, says new study
Close collaboration between family doctors and periodontists and other oral health professionals is necessary for an effective prevention, early detection and management of widespread systemic health conditions, affecting millions of patients everywhere.
8,000 steps once or twice a week cuts mortality risk: Study
Walking 8,000 steps—about four miles (6.4 kilometers)—one or two days a week may significantly reduce the risk of an early death, according to a study released on Tuesday.
A plant-based compound that inhibits reactivation of the HIV viral reservoir, giving the immune system a break
As of 2022, approximately 1.2 million people in the United States are living with HIV. Antiretroviral therapies have enabled many of these individuals to live productive, symptom-free lives, but a cure that permanently eliminates HIV from an infected person’s body is still a long way off. However, researchers at The Wistar Institute, an international biomedical research institute in the areas of cancer, immunology, infectious disease, and vaccine development, have zeroed in on a promising compound that targets HIV reservoirs that persist in people living with HIV despite the presence of anti-HIV therapy.
Dual HIV-syphilis rapid test approved for use in Canada
Federal regulators have approved the licensure of an all-in-one rapid device that allows Canadians to simultaneously be tested for HIV and syphilis. Canada is the first country to approve and implement a dual-target device in North America that can produce results in as little as 60 seconds.
Can artificial intelligence be used to diagnose influenza?
The recently published article “Examining the Use of an Artificial Intelligence Model to Diagnose Influenza: Development and Validation Study” in the Journal of Medical Internet Research, reported that it may be possible to diagnose influenza infection by applying deep learning to pharyngeal images given that influenza primarily infects the upper respiratory system.
Study finds a strong correlation between elevated hypertension and irregular sleep patterns
Hard-working executives and trade workers might think shift work or even slight changes in their regular sleep patterns and duration make no difference to their overall night’s rest and recovery—but think again.
Scientists shed new light on two proteins that exacerbate the progression of Parkinson’s disease
Two proteins may be intimately linked to the progression of Parkinson’s disease, a relentless and disabling neurodegenerative disorder that affects millions of people around the world.
Team designs molecule to disrupt SARS-CoV-2 infection
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.